Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 26 results found. Search for [ Eli Lilly COVID-19 treatment ]

Results 1 to 21 of 26
BusinessToday.In
January 27, 2021
The American biotech company said its two-antibody cocktail, REGEN-COV, caused a 100% reduction in symptomatic infection and roughly 50% lower overall rates of infection


Reuters
December 3, 2020
The new purchase is part of a US government deal to secure nearly 1 million doses of Lilly's bamlanivimab


Reuters
November 11, 2020
The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data


PTI
October 31, 2020
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients


PTI
October 27, 2020
Speaking to reporters after a meeting with AstraZeneca Managing Director Gagan Singh Bedi, he said the first phase of trials of the vaccine were encouraging


Reuters
October 27, 2020
President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month


PB Jayakumar
October 22, 2020
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


PTI
October 14, 2020
Trump, who tested positive for COVID-19 on October 1 and was admitted to a military hospital for three nights and four days, declared himself cured after he was treated with an experimental antibody drug cocktail


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


Reuters
October 10, 2020
The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19


BusinessToday.In
New Delhi, October 9, 2020
Eli Lilly, Gates Foundation sign deal to supply COVID-19 drugs to low, middle-income countriesEli Lilly and Co said on Thursday it had entered into an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for COVID-19 to low and middle-income countries. As part of the deal, Lilly said it will make antibody therapies available to lower-income countries prior to April 2021, but did not elaborate on the number of doses. Separately, F...


Reuters
October 9, 2020
Lilly had previously said it would make one million doses of its single antibody treatment available by the end of the year


PTI
October 8, 2020
Trump was admitted to Walter Reed National Medical Center last Friday, a day after he and First Lady Melania Trump tested positive for COVID-19


Joe C Mathew
October 3, 2020
The two countries argue that in the absence of a waiver, existing protection for intellectual property rights such as patents, industrial designs, copyright and protection of undisclosed information, may create barriers to timely access to affordable medical products


Associated Press
August 4, 2020
The Trump administration responds that nursing homes could cover the cost of ongoing testing from a 5 billion pot provided by Congress, and allocated to the facilities by the White House


Reuters
August 4, 2020
The Phase III trial is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19


Reuters
July 31, 2020
Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv


PB Jayakumar
June 11, 2020
While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks


PAGES 1 OF 2  12